COVID-19 Notice: 
Novo Nordisk Information and Resources. Click here.

What does this rFVIIa treatment mean for you?

NovoSeven® RT means speed, effectiveness and portability. It’s a recombinant bypassing agent that you infuse on-demand, and has a long history of helping people control their bleeds.

Take a Closer Look

What does this rFVIIa treatment mean for you?

NovoSeven® RT means speed, effectiveness and portability. It’s a recombinant bypassing agent that you infuse on-demand, and has a long history of helping people control their bleeds.

Take a Closer Look

NovoSeven® RT is used to treat more types of bleeding disorders than any other factor product.

Syringe and vials of NovoSeven® RT (Coagulation Factor VIIa [Recombinant])

What is the safety profile of NovoSeven® RT?

NovoSeven® RT is engineered for recombinant safety. It is manufactured to minimize the possibility of viral contamination, and undergoes an extensive 5-step purification process. And studies show NovoSeven® RT has a low rate of thrombotic adverse events (blood clots).a

The most common and serious side effects are blood clots.

View safety information

aIn people with hemophilia A or B with inhibitors.

Male and Female standing

Who uses NovoSeven® RT?

People who use NovoSeven® RT are talking about fast infusion time, and portability makes it possible to take their treatment along when they’re on the go. You may find that their experiences are similar to yours.

Hear their stories

What is the safety profile of NovoSeven® RT?

NovoSeven® RT is engineered for recombinant safety. It is manufactured to minimize the possibility of viral contamination, and undergoes an extensive 5-step purification process. And studies show NovoSeven® RT has a low rate of thrombotic adverse events (blood clots).a

The most common and serious side effects are blood clots.

View safety information

aIn people with hemophilia A or B with inhibitors.

Who uses NovoSeven® RT?

People who use NovoSeven® RT are talking about fast infusion time, and portability makes it possible to take their treatment along when they’re on the go. You may find that their experiences are similar to yours.

Hear their stories

How can we help?

Novo Nordisk Hemophilia Community Liaisons (HCLs) are here to answer your questions about NovoSeven® RT and connect you with resources to help you manage your bleeding disorder.

Connect With an HCL

New to NovoSeven® RT?

Here’s how to get started:

New to NovoSeven® RT? Here’s how to get started:

I have just been prescribed NovoSeven® RT.

Let’s Get Started

I am considering NovoSeven® RT.

Learn About Options

Selected Important Safety Information

What is the most important information I should know about NovoSeven® RT?

NovoSeven® RT may cause serious side effects, including:

  • Serious blood clots that form in veins and arteries with the use of NovoSeven® RT have been reported
  • Your healthcare provider should discuss the risks and explain the signs and symptoms of blood clots to you. Some signs of a blood clot may include pain, swelling, warmth, redness, or a lump in your legs or arms, chest pain, shortness of breath, or sudden severe headache and/or loss of consciousness or function
  • Your healthcare provider should monitor you for blood clots during treatment with NovoSeven® RT

What is NovoSeven® RT?

NovoSeven® RT (coagulation Factor VIIa, recombinant) is an injectable medicine used for:

  • Treatment of bleeding and prevention of bleeding for surgeries and procedures in adults and children with hemophilia A or B with inhibitors, congenital Factor VII (FVII) deficiency, and Glanzmann’s thrombasthenia with a decreased or absent response to platelet transfusions
  • Treatment of bleeding and prevention of bleeding for surgeries and procedures in adults with acquired hemophilia

Important Safety Information

What is the most important information I should know about NovoSeven® RT?

NovoSeven® RT may cause serious side effects, including:

  • Serious blood clots that form in veins and arteries with the use of NovoSeven® RT have been reported
  • Your healthcare provider should discuss the risks and explain the signs and symptoms of blood clots to you. Some signs of a blood clot may include pain, swelling, warmth, redness, or a lump in your legs or arms, chest pain, shortness of breath, or sudden severe headache and/or loss of consciousness or function
  • Your healthcare provider should monitor you for blood clots during treatment with NovoSeven® RT
  • You should not use NovoSeven® RT if you have ever had allergic (hypersensitivity) reactions, including severe, whole body reactions (anaphylaxis) to NovoSeven® RT, any of its ingredients, or mice, hamsters, or cows. Signs of allergic reaction include shortness of breath, rash, itching (pruritus), redness of the skin (erythema), or fainting/dizziness

What should I tell my healthcare provider before using NovoSeven® RT?

  • Tell your healthcare provider if you have any of the following, as these may increase your risk of blood clots:
    • congenital hemophilia and are also receiving treatment with aPCCs (activated prothrombin complex concentrates)
    • are an older patient particularly with acquired hemophilia and receiving other agents to stop bleeding
    • history of heart or blood vessel diseases
  • Tell your healthcare provider and pharmacist about all the medicines you take, including all prescription and non-prescription medicines, such as over-the-counter medicines, supplements, or herbal remedies

What are the possible side effects of NovoSeven® RT?

  • The most common and serious side effects are blood clots
  • Tell your healthcare provider about any side effects that bother you or do not go away, and seek medical help right away if you have signs of a blood clot or allergic reaction

Please click here for Prescribing Information